These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37072108)

  • 21. Positive
    Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
    Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current TNM system of the UICC/AJCC : the prognostic significance for differentiated thyroid carcinoma].
    Stratmann M; Sekulla C; Dralle H; Brauckhoff M
    Chirurg; 2012 Jul; 83(7):646-51. PubMed ID: 22273853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.
    Huang BY; Hseuh C; Chao TC; Lin KJ; Lin JD
    Endocr Pathol; 2011 Sep; 22(3):144-9. PubMed ID: 21647844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tall cell variant papillary thyroid carcinoma impacts disease-free survival at the 10 % cut-point on multivariate analysis.
    Samankan S; Militello L; Seo G; Everest S; O'Malley Q; Spaulding SL; Xing M; Matloob A; Beute J; Chai R; Doyle S; Urken ML; Brandwein-Weber M
    Pathol Res Pract; 2022 Aug; 236():154012. PubMed ID: 35834884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The miR-199a-5p/PD-L1 axis regulates cell proliferation, migration and invasion in follicular thyroid carcinoma.
    Lin J; Qiu Y; Zheng X; Dai Y; Xu T
    BMC Cancer; 2022 Jul; 22(1):756. PubMed ID: 35818041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive screening for PD-L1 expression in thyroid cancer.
    Ahn S; Kim TH; Kim SW; Ki CS; Jang HW; Kim JS; Kim JH; Choe JH; Shin JH; Hahn SY; Oh YL; Chung JH
    Endocr Relat Cancer; 2017 Feb; 24(2):97-106. PubMed ID: 28093480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    van Velsen EFS; Visser WE; Stegenga MT; Mäder U; Reiners C; van Kemenade FJ; van Ginhoven TM; Verburg FA; Peeters RP
    Thyroid; 2021 Jul; 31(7):1041-1049. PubMed ID: 33487121
    [No Abstract]   [Full Text] [Related]  

  • 29. PROGRAMMED CELL DEATH-LIGAND 1 OVEREXPRESSION IN THYROID CANCER.
    Zhang GQ; Wei WJ; Song HJ; Sun ZK; Shen CT; Zhang XY; Chen XY; Qiu ZL; Luo QY
    Endocr Pract; 2019 Mar; 25(3):279-286. PubMed ID: 30913016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma.
    Bai Y; Niu D; Huang X; Jia L; Kang Q; Dou F; Ji X; Xue W; Liu Y; Li Z; Feng Q; Lin D; Kakudo K
    Diagn Pathol; 2017 Oct; 12(1):72. PubMed ID: 28974264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DEATH RELATED TO PULMONARY METASTASIS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER.
    Leite AK; Kulcsar MA; de Godoi Cavalheiro B; de Mello ES; Alves VA; Cernea CR; Matos LL
    Endocr Pract; 2017 Jan; 23(1):72-78. PubMed ID: 27749128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PD-L1 Expression and Ultrasound Characteristics in Papillary Thyroid Carcinoma and Its Effect on Recurrence.
    Li R; Li M; Sun B; Qi M; Peng C; Li H; Zheng S; Liu Q; Jiang C
    In Vivo; 2023; 37(6):2820-2828. PubMed ID: 37905619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioactive iodine (RAI) therapy for distantly metastatic differentiated thyroid cancer (DTC) in juvenile versus adult patients.
    Kammori M; Fukumori T; Sugishita Y; Hoshi M; Shimizu K; Yamada T
    Endocr J; 2015; 62(12):1067-75. PubMed ID: 26424174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer.
    Zhang GQ; Jiao Q; Shen CT; Song HJ; Zhang HZ; Qiu ZL; Luo QY
    Cancer Sci; 2021 Mar; 112(3):997-1010. PubMed ID: 33247999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
    Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA
    Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases.
    Yu XM; Schneider DF; Leverson G; Chen H; Sippel RS
    Thyroid; 2013 Oct; 23(10):1263-8. PubMed ID: 23477346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RISK FACTORS FOR NONREMISSION AND PROGRESSION-FREE SURVIVAL AFTER I-131 THERAPY IN PATIENTS WITH LUNG METASTASIS FROM DIFFERENTIATED THYROID CANCER: A SINGLE-INSTITUTE, RETROSPECTIVE ANALYSIS IN SOUTHERN CHINA.
    Chen P; Feng HJ; Ouyang W; Wu JQ; Wang J; Sun YG; Xian JL; Huang LH
    Endocr Pract; 2016 Sep; 22(9):1048-56. PubMed ID: 27124694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do Molecular Profiles of Primary
    Gomes-Lima CJ; Shobab L; Wu D; Ylli D; Bikas A; McCoy M; Feldman R; Lee W; Rao SN; Jensen K; Vasko V; Castro LC; Jonklaas J; Wartofsky L; Burman KD
    Front Endocrinol (Lausanne); 2021; 12():623182. PubMed ID: 33716974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
    Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
    J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting disease-free status of differentiated thyroid carcinoma patients.
    Thamnirat K; Utamakul C; Chamroonrat W; Kositwattanarerk A; Anongpornjossakul Y; Sritara C
    Asian Pac J Cancer Prev; 2015; 16(2):737-40. PubMed ID: 25684517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.